Cyclophanes for live-cell imaging
US-11904025-B2 · Feb 20, 2024 · US
US10758630B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10758630-B2 |
| Application number | US-201213622666-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 19, 2012 |
| Priority date | Aug 13, 2010 |
| Publication date | Sep 1, 2020 |
| Grant date | Sep 1, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A topical composition includes a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein. The hydrophobic particles are derived from the same or different hydrophobic material and each hydrophobic particle has a melting point below the melting point of the respective hydrophobic material. The hydrophobic particles comprise a mean particle size of less than about 10 nm, and the nanoemulsion further includes one or more pharmaceutically active agents.
Opening claim text (preview).
What is claimed is: 1. A topical composition comprising a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein, wherein the hydrophobic particles are derived from the same or different bulk hydrophobic material and each hydrophobic particle has a melting point less than the melting point of the respective bulk hydrophobic material, the hydrophobic particles comprise a mean particle size of less than 8 nm, said hydrophilic coating consists of one or more non-ionic surfactants, and the nanoemulsion further comprises at least one pharmaceutically active agent; wherein the bulk hydrophobic material has a melting point of from about 21° C. to about 33° C. 2. The topical composition of claim 1 , wherein the hydrophobic particles comprise a mean particle size of less than 8 nm with a polydispersity of less than about 5%. 3. The topical composition of claim 1 , wherein the hydrophobic particles comprise a mean particle size of less than 8 nm with a polydispersity of less than about 3%. 4. The topical composition of claim 1 , wherein the hydrophobic material is selected from the group consisting of a wax, butter and combinations thereof. 5. The topical composition of claim 1 , wherein the one or more non-ionic surfactants is selected from the group consisting of a fatty alcohol, a polyoxyalkylene alkyl ether, a polyoxyalkylene alkenyl ether, a polyoxyethylene glycol octylphenol ether, a polyethylene glycol alkyl ether, a polyglyceryl fatty acid ester, a fatty acid mono- or diethanolamide, a polyoxyethylene hydrogenated castor oil, a polyoxyethylene sorbitan fatty acid ester, a polyoxyethylene fatty acid ester, a sorbitan ester, a sucrose ester, an alkyl-saccharide-based surfactant, an alkylamine oxide, an alkylamidoamine oxide and mixtures thereof. 6. A topical composition comprising a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein, wherein the hydrophobic particles are derived from the same or different bulk hydrophobic material and each hydrophobic particle has a melting point less than the melting point of the respective bulk hydrophobic material, said hydrophilic coating consists of one or more non-ionic surfactants; wherein the hydrophobic particles comprise a mean particle size of less than 8 nm, and wherein the nanoemulsion further comprises at least one pharmaceutically active agent relating to hirsutism or alopecia and; wherein the bulk hydrophobic material has a melting point of from about 21° C. to about 33° C. 7. The topical composition of claim 6 , wherein the hydrophobic particles comprise a mean particle size of less than 8 nm with a polydispersity of less than about 10%. 8. The topical composition of claim 6 , wherein the hydrophobic particles comprise a mean particle size of less than 8 nm with a polydispersity of less than about 5%. 9. The topical composition of claim 6 , wherein the at least one pharmaceutically active agent relating to hirsutism or alopecia comprises cyclosporine, FK506, minoxidil, or mixtures thereof. 10. The topical composition of claim 6 , wherein the hydrophobic material is selected from the group consisting of a wax, butter and combinations thereof. 11. A method for treating hirsutism or alopecia, the method comprising contacting an area of a host with a therapeutically effective amount of a topical composition comprising a nanoemulsion of a plurality of hydrophobic particles having a hydrophilic coating therein, wherein the hydrophobic particles are derived from the same or different bulk hydrophobic material and each hydrophobic particle has a melting point less than the melting point of the respective bulk hydrophobic material, the hydrophobic particles comprise a mean particle size of less than 8 nm, said hydrophilic coating consists of one or more non-ionic surfactants, and the nanoemulsion further comprises at least one pharmaceutically active agent relating to hirsutism or alopecia; wherein the bulk hydrophobic material has a melting point of from about 21° C. to about 33° C. 12. The method of claim 11 , wherein the at least one pharmaceutically active agent relating to hirsutism or alopecia comprises cyclosporine, FK506, minoxidil, or mixtures thereof. 13. The topical composition of claim 1 , further comprising a chemiluminescent detecting system comprising a peroxide-reactive compound and a light-emitting material. 14. The topical composition of claim 1 , further comprising a preservative. 15. The topical composition of claim 14 , wherein the preservative comprises butylparaben, propylparaben, chlorocresol, sorbic acid, benzoic acid, or combinations thereof. 16. The topical composition of claim 1 , wherein the topical composition is loaded onto a transdermal patch. 17. The method of claim 11 , wherein the topical composition is loaded onto a transdermal patch and said step of contacting an area of a host with a therapeutically effective amount of a topical composition comprises applying the transdermal patch onto the area. 18. The topical composition of claim 6 , further comprising a preservative. 19. The method of claim 11 , wherein the topical composition further comprises a preservative.
microemulsion, nanoemulsion · CPC title
the fluorescent group being a small organic molecule · CPC title
Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14) · CPC title
Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers (A61K9/0026 takes precedence) · CPC title
Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.